Texas Abortion Ban Linked to Increased Critical Illness in High-Risk Pregnant Patients

Maternal Critical Illness and Policy Implications

Critical illness during pregnancy, though infrequent, carries significant risk for maternal morbidity and mortality. Conditions such as sepsis, a dysregulated host response to infection leading to organ dysfunction, and respiratory failure requiring mechanical ventilation are primary drivers of these adverse outcomes [1, 2, 3, 4, 5]. Clinicians are well aware of the complexities in managing these patients, where conditions like severe pneumonia or COVID-19 can profoundly affect both maternal and perinatal health [6, 5]. A recent study now provides quantitative data on how a major legislative policy change may be associated with the incidence of critical illness among hospitalized pregnant women.

Study Design and Patient Cohort

The investigation was prompted by the September 2021 enactment of Texas Senate Bill 8 (SB8), which banned abortion after the detection of embryonic cardiac activity. To assess the law's potential association with maternal health outcomes, researchers designed an interrupted time series study. This quasi-experimental method is particularly well suited for evaluating policy impacts, as it analyzes long-term data to distinguish changes in trends after a specific event from the trends that were already occurring. The analysis drew from a retrospective cohort of 2,344,135 pregnant women aged 10 to 54 who were hospitalized in Texas between January 2018 and March 2024. A key component of the study was the identification of a high-risk subgroup of 497,144 patients, defined as those younger than 18, older than 34, or having at least one chronic illness.

Defining Critical Outcomes

The study's primary outcome was a composite measure of critical illness, defined as the occurrence of either sepsis or the need for mechanical ventilation. Secondary outcomes included sepsis and mechanical ventilation analyzed individually, as well as the incidence of infection without accompanying organ dysfunction. The interrupted time series analysis produced two main metrics to quantify the association with SB8. The first, an immediate step change, measures any abrupt spike or drop in rates occurring immediately after the policy was implemented. The second, a sustained slope change, is often more clinically relevant for policy evaluation. It measures the difference in the rate of change over time, comparing the post-policy trend to the pre-policy trend, thereby revealing if the policy was associated with a gradual, continuing alteration in outcomes.

Differential Impact on Patient Subgroups

In the full cohort of over 2.3 million hospitalized pregnant women, the study found no statistically significant association between the implementation of SB8 and the rates of critical illness, sepsis, mechanical ventilation, or infection in adjusted analyses. This suggests the policy's effects were not uniform across the entire pregnant population. However, the analysis uncovered a crucial demographic shift. Following SB8, there was a significant and sustained increase in the proportion of hospitalized pregnant patients who had high-risk features. This was quantified as a slope change of 0.92 additional high-risk patients per quarter per 1,000 hospitalizations (95% CI, 0.08 to 1.77). For all outcomes, the researchers found no significant immediate step changes, indicating the associations represented a gradual accumulation over time rather than an instantaneous shock to the system.

Increased Critical Illness in High-Risk Patients

The clinical consequences of SB8 became apparent when the analysis focused on the high-risk subgroup of nearly 500,000 patients. In this vulnerable population, the policy was associated with a sustained increase in the rate of critical illness, with a slope change of 0.17 additional cases per quarter per 1,000 hospitalizations (95% CI, 0.02 to 0.33). This demonstrates a gradual but persistent rise in severe complications among these women. Dissecting this further, the rate of sepsis showed a similar sustained increase, with a slope change of 0.15 per quarter per 1,000 hospitalizations (95% CI, 0.02 to 0.28). The most pronounced effect was on infection rates, which saw a slope change of 1.60 per quarter per 1,000 hospitalizations (95% CI, 1.02 to 2.17). In contrast, the rate of mechanical ventilation alone did not show a statistically significant change (slope change: 0.05; 95% CI, -0.03 to 0.13), suggesting the primary drivers of increased critical illness were infectious in nature.

Clinical Implications for Practice and Policy

These findings have direct relevance for physicians managing pregnant patients, especially in states with restrictive abortion laws. The data show that following the implementation of SB8, hospitalized pregnant women with high-risk features experienced a sustained increase in rates of critical illness, sepsis, and infection. For clinicians, this finding reinforces the need for heightened vigilance, proactive risk stratification, and a lower threshold for investigating potential infectious processes in this patient group. The documented rise in sepsis and infections suggests that delays in care or continuation of pregnancies with more complex underlying medical conditions may be contributing to this increased morbidity. The authors conclude that these results should inform the development of targeted infection prevention programs and expanded critical illness training in states with similar policies. For the practicing physician, this study provides quantitative evidence that legislative changes affecting reproductive health can correlate with tangible, adverse maternal health outcomes, necessitating adjustments in clinical surveillance and systemic resource allocation.

References

1. Rangel-Huerta ÓD, Aguilera CM, Mesa MD, Gil Á. Omega-3 long-chain polyunsaturated fatty acids supplementation on inflammatory biomakers: a systematic review of randomised clinical trials. British Journal Of Nutrition. 2012. doi:10.1017/s0007114512001559

2. Purnamasari N, Azhari R. The Relation Between 25-Hydroxyvitamin D Levels and Sepsis in Neonatal Intensive Care Unit Infants: A Comprehensive Systematic Review. International journal of medical science and health research. 2025. doi:10.70070/zhjype47

3. Messmer AS, Zingg C, Müller M, Gerber JL, Schefold JC, Pfortmueller CA. Fluid Overload and Mortality in Adult Critical Care Patients—A Systematic Review and Meta-Analysis of Observational Studies*. Critical Care Medicine. 2020. doi:10.1097/ccm.0000000000004617

4. Metlay JP, Waterer G, Long AC, et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. American Journal of Respiratory and Critical Care Medicine. 2019. doi:10.1164/rccm.201908-1581st

5. Wiersinga WJ, Rhodes A, Cheng A, Peacock SJ, Prescott HC. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19). JAMA. 2020. doi:10.1001/jama.2020.12839

6. Deng J, Ma Y, Liu Q, Du M, Liu M, Liu J. Association of Infection with Different SARS-CoV-2 Variants during Pregnancy with Maternal and Perinatal Outcomes: A Systematic Review and Meta-Analysis.. International journal of environmental research and public health. 2022. doi:10.3390/ijerph192315932